Clinical Trials Browser

Interventional × Has results × belinostat × Clear all

NCT02737046 2026-03-10

Belinostat Therapy With Zidovudine for Adult T-Cell Leukemia-Lymphoma

Phase 2 Completed

15 enrolled 13 charts

LymphoidOther hematologic neoplasm

Leukemia-Lymphoma, Adult T-Cell

NCT03772925 2026-03-03

Pevonedistat and Belinostat in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

Phase 1 Terminated

18 enrolled 19 charts

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT00865969 2021-10-29

PTCL

Phase 2 Completed

129 enrolled 12 charts

Lymphoma, T-Cell, Peripheral

NCT00993616 2019-07-23

Belinostat and Carboplatin in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Carboplatin or Cisplatin

Phase 2 Completed

29 enrolled 9 charts

Carcinoma, Ovarian Epithelial, Brenner Tumor, Fallopian Tube Neoplasms

NCT01273155 2019-03-26

Belinostat for Solid Tumors and Lymphomas in Patients With Varying Degrees of Hepatic Dysfunction

Phase 1 Completed

72 enrolled 23 charts

Liver Diseases, Lymphoma, Neoplasms

NCT01686165 2018-08-28

Belinostat and Yttrium Y 90 Ibritumomab Tiuxetan in Patients W/Relapsed Aggressive B-Cell NHL

Phase 2 Completed

5 enrolled 8 charts

Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Mantle-Cell

NCT00301756 2018-08-20

Belinostat in Treating Patients With Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer or Ovarian Low Malignant Potential Tumors

Phase 2 Completed

32 enrolled 11 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00365053 2018-06-07

PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By Surgery

Phase 2 Completed

13 enrolled 7 charts

Other solid neoplasmThoracic

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural

NCT00357032 2018-04-17

PXD101 in Treating Patients With Acute Myeloid Leukemia

Phase 2 Completed

12 enrolled 6 charts

Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Myeloid, Acute

NCT00321594 2017-11-06

Belinostat in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

Phase 1/2 Completed

54 enrolled 8 charts

Gastrointestinal

Carcinoma, Hepatocellular

NCT00589290 2015-09-30

Belinostat (PXD101) to Treat Tumors of the Thymus at an Advanced Stage

Phase 2 Completed

41 enrolled 8 charts

Mediastinal Neoplasms, Thymoma

NCT00274651 2015-07-28

PXD101-CLN-6

Phase 2 Terminated

53 enrolled 12 charts

DermatologicLymphoid

Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral

NCT00421889 2015-07-28

A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse Treatment

Phase 1/2 Completed

80 enrolled 19 charts

GenitourinaryGynecologic

Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00873119 2015-07-28

Belinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer of Unknown Primary

Phase 2 Completed

89 enrolled 12 charts

Neoplasms, Unknown Primary

NCT00878722 2015-07-28

Trial of PXD101 (Belinostat) in Combination With Idarubicin to Treat AML Not Suitable for Standard Intensive Therapy

Phase 1/2 Completed

41 enrolled 22 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00878800 2015-07-28

A Phase I/II Clinical Trial of PXD101 in Combination With Doxorubicin in Patients With Soft Tissue Sarcomas

Phase 1/2 Completed

41 enrolled 18 charts

Sarcoma

NCT00303953 2014-05-12

PXD101 in Treating Patients With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma

Phase 2 Completed

22 enrolled 8 charts

Burkitt Lymphoma, Lymphoma, Large B-Cell, Diffuse